Press release
Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease Pipeline Assessment, 2023 | In-depth Insights into the Clinical Trials, Emerging Drugs, Latest FDA, EMA, and PMDA Approvals, and Treatment Outlook | Key Companies - Takeda/Arrowhead Pharmaceuticals (faz
"Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease Therapeutics Market.
The report provides a detailed description of the drug, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any).
The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.
Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease Pipeline Analysis
The report provides insights into:
- The report provides detailed insights into the key companies that are developing therapies in the Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease Market.
- The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease treatment.
- It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
- It navigates the emerging drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
- Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement of the Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
The Report Covers the Emerging Pipeline Products Under Different Phases of Clinical Development Like -
- Late-stage products (Phase III)
- Mid-stage products (Phase II)
- Early-stage products (Phase I)
- Pre-clinical and Discovery stage candidates
- Discontinued & Inactive candidates
Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease Emerging Therapies Mechanism of Action Type -
- RNA interference
- Alpha 1 antitrypsin modulators
- Alpha 1 antitrypsin inhibitors
- Leucocyte elastase inhibitors
- Gene transference
Request for Sample PDF to Understand More About the Treatment Outlook and Future Perspectives:
https://www.delveinsight.com/report-store/alpha-1-antitrypsin-deficiency-liver-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Latest Clinical, Commercial, and Regulatory Developments in the Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease Therapeutics Market
- On January 09, 2023, Takeda (TSE:4502/NYSE:TAK) and Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) announced topline results from the Phase 2 SEQUOIA clinical study of investigational fazirsiran (TAK-999/ARO-AAT) for the treatment of liver disease associated with alpha-1 antitrypsin deficiency (AATD-LD).
- In July 2021, Arrowhead Pharmaceuticals announced that it was granted Breakthrough Therapy designation (BTD) by the US FDA for ARO-AAT, also known as TAK-999, being co-developed with Takeda Pharmaceutical Company as a treatment for the rare genetic liver disease associated with alpha-1 antitrypsin deficiency (AATD).
- In July 2021, Dicerna Pharmaceuticals announced interim results from the four completed active-treatment dose cohorts (0.1, 1.0, 3.0, and 6.0 mg/kg) of its Phase I double-blind, placebo-controlled, randomized trial of belcesiran, an investigational GalXC™ RNAi therapeutic in development for the treatment of alpha-1 antitrypsin deficiency-associated liver disease (AATLD).
Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease Therapeutics Analysis
There are approx. 8+ key companies which are developing the therapies for Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease. Currently, Arrowhead Pharmaceuticals is leading the therapeutics market with its Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease drug candidates in the most advanced stage of clinical development.
The Leading Companies in the Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease Therapeutics Market Include:
- Centessa Pharmaceuticals
- Dicerna Pharmaceuticals
- PH Pharmaceuticals
- Arrowhead Pharmaceuticals
- Alnylam Pharmaceuticals
- LogicBio Therapeutics
- WaVe life Sciences
- Wuhan Healthgen Biotechnology
- Apic Bio
And Many Others
Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease Drugs Covered in the Report Include:
- ARO-AAT: Arrowhead Pharmaceuticals
- ZF874: Centessa Pharmaceuticals
- APB-101: Apic Bio
- Belcesiran: Dicerna Pharmaceuticals
- LIQ861: Liquidia Technologies
- Sotatercept: Acceleron Pharma
And Many More
Get an in-depth Assessment of the Emerging Therapies and Key Companies:
https://www.delveinsight.com/sample-request/alpha-1-antitrypsin-deficiency-liver-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Table of Content
1. Report Introduction
2. Executive Summary
3. Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease Current Treatment Patterns
4. Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease Late-Stage Products (Phase-III)
7. Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease Discontinued Products
13. Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease Product Profiles
14. Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease Key Companies
15. Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease Key Products
16. Dormant and Discontinued Products
17. Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease Unmet Needs
18. Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease Future Perspectives
19. Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease Analyst Review
20. Appendix
21. Report Methodology
Get Detailed Insights About the Reports Offerings:
https://www.delveinsight.com/sample-request/alpha-1-antitrypsin-deficiency-liver-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Trending Market Research Reports 2032 | DelveInsight
Technical Due Diligence Firms- https://www.delveinsight.com/consulting/due-diligence-services
Vital Sign Monitors Devices Market- https://www.delveinsight.com/report-store/vital-sign-monitors-external-remote-patient-monitoring-devices-market
Stem Cell Market- https://www.delveinsight.com/report-store/stem-cell-market
Anastomosis Device Market- https://www.delveinsight.com/report-store/anastomotic-leak-devices-market
Asperger Syndrome Market- https://www.delveinsight.com/report-store/asperger-syndrome-market
B-Cell Maturation Antigen Targeted Therapies Market- https://www.delveinsight.com/report-store/b-cell-maturation-antigen-targeted-therapies-market
UK Healthcare Report- https://www.delveinsight.com/report-store/uk-healthcare-outlook-report
Oncolytic Virus Cancer Therapy Pipeline- https://www.delveinsight.com/report-store/oncolytic-virus-cancer-therapy-pipeline-insight-2021
Shingles Market- https://www.delveinsight.com/report-store/shingles-market
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Contact Info:
Shruti Thakur
Manager (Marketing & Branding)
Email: info@delveinsight.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease Pipeline Assessment, 2023 | In-depth Insights into the Clinical Trials, Emerging Drugs, Latest FDA, EMA, and PMDA Approvals, and Treatment Outlook | Key Companies - Takeda/Arrowhead Pharmaceuticals (faz here
News-ID: 2897468 • Views: …
More Releases from DelveInsight Business Research
Niemann-Pick Type C Pipeline Report Showcases Emerging Drugs and Leading Compani …
DelveInsight's, "Niemann Pick C Disease Pipeline Insight, 2025" report provides comprehensive insights about 10+ companies and 15+ pipeline drugs in Niemann Pick C Disease pipeline landscape. It covers the Niemann-Pick Type C pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Niemann-Pick Type C pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this…
Pemphigus Vulgaris Market Positioned for Accelerated Development Through 2034, D …
DelveInsight's "Pemphigus Vulgaris Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Pemphigus Vulgaris, historical and forecasted epidemiology as well as the Pemphigus Vulgaris market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Pemphigus Vulgaris market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Pemphigus Vulgaris Market Forecast
https://www.delveinsight.com/sample-request/pemphigus-vulgaris-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Osteogenesis Imperfecta Market to Evolve Rapidly Over the Next Decade by 2034, D …
The Osteogenesis Imperfecta market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Osteogenesis Imperfecta pipeline products will significantly revolutionize the Osteogenesis Imperfecta market dynamics.
DelveInsight's "Osteogenesis Imperfecta Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Osteogenesis Imperfecta, historical and forecasted epidemiology as well as the Osteogenesis Imperfecta market trends in the United…
Myopic Macular Degeneration Market Insights Highlight Expanding Outlook Till 203 …
DelveInsight's "Myopic Macular Degeneration Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Myopic Macular Degeneration, historical and forecasted epidemiology as well as the Myopic Macular Degeneration market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
The latest healthcare forecast report provides an in-depth analysis of Myopic Macular Degeneration, offering comprehensive insights into the Myopic Macular Degeneration revenue trends,…
More Releases for Alpha
Alpha Heater Portable Heater Reviews - Does Alpha Heater Really Work?
Alpha heater is a small plug-in heater that helps keep a room at a comfortable temperature. As it doesn't have any additional parts that could use a lot of energy or space, you will definitely save money on your electricity bills.
Read This Honest Review of Alpha Heater Before Buying!
Alpha heater is a small plug-in heater that helps keep a room at a comfortable temperature. As it doesn't have any additional…
"Alpha Alpha Tonic" - [Alpha Tonic Reviews] Does it Works? Real Price or How to …
𝐀𝐥𝐩𝐡𝐚 𝐓𝐨𝐧𝐢𝐜 𝐑𝐞𝐯𝐢𝐞𝐰 is designed to boost Tes_terone levels normally. When used as guided, men ought to experience an improvement in physical efficiency, cognition, muscle mass interpretation, and complete fat-burning rate.
𝐏𝐫𝐨𝐝𝐮𝐜𝐭 𝐍𝐚𝐦𝐞:- 𝐀𝐥𝐩𝐡𝐚 𝐓𝐨𝐧𝐢𝐜
𝐈𝐧𝐠𝐫𝐞𝐝𝐢𝐞𝐧𝐭𝐬:- 𝐁𝐨𝐫𝐨𝐧, 𝐅𝐞𝐧𝐮𝐠𝐫𝐞𝐞𝐤
𝐑𝐚𝐭𝐢𝐧𝐠:- ⭐⭐⭐⭐⭐
𝐒𝐢𝐝𝐞 𝐄𝐟𝐟𝐞𝐜𝐭𝐬:- 𝐍𝐨𝐭 𝐘𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭𝐞𝐝 𝐒𝐚𝐭𝐢𝐬𝐟𝐢𝐞𝐝
𝐂𝐮𝐬𝐭𝐨𝐦𝐞𝐫:-𝟏𝐌+
𝐅𝐃𝐀-𝐀𝐩𝐩𝐫𝐨𝐯𝐞𝐝:- 𝐘𝐞𝐬 𝐂𝐮𝐬𝐭𝐨𝐦𝐞𝐫
𝐑𝐚𝐭𝐢𝐧𝐠𝐬:- 𝟗.𝟗/𝟏𝟎…
Alpha Heater Truth EXPOSED? Alpha Heater Reviews (Buyer's Guide 2022)
We are in the middle of winter, so what plans do you have to withstand the cold without breaking the bank? Being without a heater during the winter may prove costly. As a traditional option, you can use your central heating system, but that has consequences.
If you still intend to use a gas, coal, or oil heater to warm your home, consider some of the problems it entails, as well…
Alpha Heater Reviews: Does Alpha Heater Really Work?
Alpha heater reviews
The winter can be a tough time when it comes to one’s pocket in the sense that most people spend a lot on money on electricity bill due to the increased cost of heating and electricity.
The winter is a season we all need to be prepared. It really require a careful and adequate arrangement to make sure everything is in order before its coming.
As the winter…
Alpha Heater in Canada: Black Friday Alpha Heater Amazon Deals
Get Alpha Heater For The Most Discounted Price >> https://rebrand.ly/AlphaHeaterCA
As temperature levels remain to fall across the USA and also Canada, The Alpha Heater could be an useful home appliance, one that heats up things up effectively and also swiftly. Utilizing this device, you can bring heat into any space of your home in an efficient fashion. Plus, the dropping temperature levels, together with work-at-home norms as well as the…
Alpha Heater Canada Review: Where to Buy Alpha Heater in Canada
Winter heat is a popular option with personal heaters. The Alpha Heater can be used by individuals to heat their homes or take them to work. Alpha Heater’s new design allows for 30% reductions in monthly electric bills compared to traditional heaters.
Did you know that traditional heaters can consume up to 1,500 watts an hour? Others use slightly higher or lower amounts. Imagine how your electricity bill looks after a…
